:::

詳目顯示

回上一頁
題名:Biotech in Hong Kong: How Biologist-Entrepreneurs Pursued "Hong Kong's Bioscience Dream"
書刊名:East Asian Science, Technology and Society: An International Journal
作者:Luk, Christine Y. L.
出版日期:2016
卷期:10:3
頁次:頁291-313
主題關鍵詞:Hong Kong SARBiotechPharmaceuticalBiologistsEntrepreneursCancer therapyBCT-100
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:31
  • 點閱點閱:6
This article aims to put Hong Kong on the map of East Asia's biotech studies by identifying the major themes of biotech innovation specific to the city-state's colonial past and postcolonial present and future. I provide evidence of a concerted effort led by biologist-entrepreneurs to promote the biotech industry in postcolonial Hong Kong. Through assessing scientific literature, media representations, business strategies, and programmatic visions of key scientist-entrepreneurs in Hong Kong's biotech enterprise, I highlight how factors such as local history and geopolitical considerations shape the emerging “Hong Kong's bioscience dream.” Using the recent discovery of a new recombinant anticancer drug, pegylated human recombinant arginase (BCT-100), as a case in point, I explore how biotech research and applications are marketed and interpreted in relation to Hong Kong's unique historical, political, and cultural context, thus making it distinct from other Asian Tigers. My analysis of the featured recombinant drug reveals a set of uniquely Hong Kong–centered cultural meanings attributed to biopharmaceutical research and benefits. This case reflects how genetic engineering and biotech research are configured and imagined within the context of the postcolonial Hong Kong Special Administrative Region.
期刊論文
1.Fu, Daiwie(20071200)。How Far Can East Asian STS Go?: A Position Paper。East Asian Science, Technology and Society: An International Journal,1(1),1-14。new window  new window
2.Cheng, Paul N.(2007)。Pegylated Recombinant Human Arginase (rhArg-peg 5,000 mw) Inhibits the In Vitro and In Vivo Proliferation of Human Hepatocellular Carcinoma through Arginine Depletion。Cancer Research,67(1),309-317。  new window
3.Axel Gelfert(20130000)。Before Biopolis: Representations of the Biotechnology Discourse in Singapore。East Asian Science, Technology and Society,7(1),103-123。new window  new window
4.Hsueh, Eddy C.(2012)。Deprivation of Arginine by Recombinant Human Arginase in Prostate Cancer Cells。Journal of Hematology and Oncology,5(17),1-6。  new window
5.Jasanoff, Sheila(2006)。Biotechnology and Empire: The Global Power of Seeds and Science。Osiris,21,273-292。  new window
6.Kaslow, David、Shiloach, Joseph(1994)。Production, Purification and Immunogenicity of a Malaria Transmission-Blocking Vaccine Candidate: TBV25H Expressed in Yeast and Purified using Nickel-NTA Agarose。Nature Biotechnology,12,494-499。  new window
7.Lam, Tin-Lun(2010)。Recombinant Human Arginase Inhibits the In Vitro and In Vivo Proliferation of Human Melanoma by Inducing Cell Cycle Arrest and Apoptosis。Pigment Cell Melanoma Research,24(2),366-376。  new window
8.Liu, Jennifer A.(2012)。Asian Regeneration? Technohybridity in Taiwan's Biotech?。East Asian Science, Technology and Society,6(3),401-414。new window  new window
9.Mussai, Francis(2015)。Arginine Dependence of Acute Myeloid Leukemia Blast Proliferation: A Novel Therapeutic Target。Blood,125(15),2386-2396。  new window
10.Sanders, Sean(2012)。Hong Kong in Focus: Asia’s Research Hub。Science,338(suppl.),1639-1657。  new window
11.Sharif, Naubahar(2010)。Rhetoric of Innovation Policy Making in Hong Kong using the Innovation Systems Conceptual Approach。Science, Technology, and Human Values,35(3),408-434。  new window
12.University Grants Committee(2007)。New Cancer Drug Breakthrough for Hong Kong。Research Frontiers: Newsletter of the Research Grants Council of Hong Kong, China,13。  new window
13.University Grants Committee(2007)。Gene Mapping Fights “Cantonese" Cancer。Research Frontiers: Newsletter of the Research Grants Council of Hong Kong, China,13。  new window
14.Wee, Joseph T. S.(2010)。Is Nasopharyngeal Cancer Really a “Cantonese Cancer”?。Chinese Journal of Cancer,29(5),517-526。  new window
15.Yuan, Robert、Hsu, M.(1995)。Hong Kong Looking Forward to 1997。Genetic Engineering News,1(Sep.),18-19。  new window
16.Zhang, Wen Jie(2013)。The Case for Semi-mandatory HPV Vaccination in China。Nature Biotechnology,31(7),590-591。  new window
17.Waldby, Catherine(20090000)。Singapore Biopolis: Bare Life in the City-State。East Asian Science, Technology and Society,3(2/3),367-383。new window  new window
會議論文
1.Baark, Erik(2005)。Innovation Policy Forensics: An Analysis of Biotechnology in Hong Kong。DRUID Tenth Anniversary Summer Conference 2005 on Dynamics of Industry and Innovation: Organizations, Networks and Systems,(會議日期: 2005/06/27-29)。Copenhagen。  new window
2.Chan, Margaret(2011)。The Worldwide Rise of Chronic Noncommunicable Diseases: A Slow-Motion Catastrophe。Opening Remarks at the First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control,(會議日期: 2011/04/28)。Moscow。  new window
3.Chang, Albert Y.(1998)。The Role of Hong Kong SAR in the Development of Biotechnology Industry in China。Joint International Meeting of the Japanese Association for Animal Cell Technology (JAACT) and the European Society for Animal Cell Technology (ESACT)。Kyoto。  new window
圖書
1.Yip, Ka-che(2009)。Disease, Colonialism, and the State: Malaria in Modern East Asian History。Hong Kong:University of Hong Kong Press。  new window
2.Wong, Joseph(2011)。Betting on Biotech: Innovation and the Limits of Asia's Developmental State。Cornell University Press。  new window
3.Bergeron, Bryan、Chan, Paul(2004)。Biotech Industry: A Global, Economic, and Financing Overview。Hoboken, NJ:John Wiley & Sons。  new window
4.Ducor, Phillip G.(1998)。Patenting the Recombinant Products of Biotechnology and Other Molecules。London:Kluwer。  new window
5.Fuller, Douglas B.(2010)。Innovation Policy and the Limits of Laissez-Faire: Hong Kong's Policy in Comparative Perspective。Basingstoke:Palgrave Macmillan。  new window
6.MacPhail, Theresa(2014)。The Viral Network: A Pathography of the H1N1 Influenza Pandemic。Ithaca, NY:Cornell University Press。  new window
7.Maienschein, Jane(2014)。Embryos under the Microscope: The Divergent Meanings of Life。Cambridge, MA:Harvard University Press。  new window
8.Rasmussen, Nicolas(2014)。Gene Jockeys: Life Science and the Rise of Biotech Enterprise。Baltimore:Johns Hopkins University Press。  new window
9.Berger, Suzanne、Lester, Richard K.(1997)。Made By Hong Kong。H.K.:Oxford:Oxford University Press。  new window
10.Ong, Aihwa、Chen, Nancy N.(2010)。Asian Biotech: Ethics and Communities of Fate。Duke University Press。  new window
11.Pisano, Gary(2006)。Science Business: The Promise, the Reality, and the Future of Biotech。Boston, MA。  new window
12.Fujimura, Joan H.(1996)。Crafting science: A sociohistory of the quest for the genetics of cancer。Cambridge, MA:Harvard University Press。  new window
13.Fisher, Jill(2009)。Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials。New Brunswick, NJ:Rutgers University Press。  new window
其他
1.American Cancer Society(20160126)。Cancer in China: More than 7500 Cancer Deaths per Day Estimated,www.sciencedaily.com/releases/2016/01/160126162209.htm。  new window
2.(20050501)。理大成功研發治肝癌藥。  延伸查詢new window
3.(2012)。BCT-100, Hong Kong’s First Novel Biologic Anti-cancer Drug,www.biocancer.org/view.asp?Id=1098&BigClassName=%D0%C2%CE%C5%D6% D0%D0%C45, 2016/03/10。  new window
4.(200207)。于常海編織香港生科夢,www.albertchyu.com.cn/media/report_2011-20.html。  延伸查詢new window
5.(2013)。康達醫療科技,香港人的驕傲,www.oncologist.hk/media-detail-1.html, 2015/04/15。  延伸查詢new window
6.Chan, Samuel(20151111)。Hong Kong’s New Innovation and Technology Bureau to Absorb Two Departments from Commerce Bureau。  new window
7.(20090310)。暴痩脫髪周啟邦睇腫瘤科名醫。  延伸查詢new window
8.(20100707)。Hong Kong’s Economy: End of an Experiment。  new window
9.Foster, Peter(20110427)。Top Ten Chinese Food Scandals。  new window
10.(20050607)。香港肝癌新藥獲國際金獎(命藥亮相)。  延伸查詢new window
11.Griffiths, James(20150313)。Could Tiny Fish Be the Answer to China’s Food Safety Woes? This Hong Kong Start-Up Thinks So。  new window
12.(20140320)。Hong Kong Science Park Phase 3 Doubles Partner Companies to Forty-Five,www.hkstp.org/en-US/News-Media-Events/Corporate -News/2014/Hong-Kong_Science-Park-Phase-3-Doubles-Partner-Coni.aspx, 2016/03/10。  new window
13.(2007)。Promoting Health in Hong Kong: A Strategic Framework for Prevention and Control of Non-communicable Disease,www.change4heaIth.gov.hk/en/strategic_framework/structure/steering_committee/promoting_health/index.html, 2016/03/10。  new window
14.Lo, Alex(20150327)。Hong Kong’s Hi-Tech Realty Is More Low End。  new window
15.Ma, Allen(20150401)。Savvy Tech Investors Showing Confidence in Hong Kong。  new window
16.(20010726)。Putting the Pieces Together: Hong Kong。  new window
17.(2009)。Study of Pegylated Human Recombinant Arginase for Liver Cancer,clinicaltrials.gov/show/NCT00988195, 2016/03/10。  new window
18.(2010)。Study of Pegylated Human Recombinant Arginase for Liver Cancer,clinicaltrials.gov/ct2/show/study/NCT01092091, 2016/03/10。  new window
19.(20120627)。「餓死癌細胞」港產藥過關。  延伸查詢new window
20.(20101108)。Asia's Biotechnology Hub in the Making。  new window
21.Steinfeld, Jemimah(20140619)。Do Chinese Classrooms Need to Talk about Sex?,www.cnn.com /2014/06/19/worId/asia/china-sex-education/。  new window
22.Tsui-Auch, Lai Si(2000)。Functional versus Sectoral Industrial Policy: A Comparative Study of the Biotechnology Development in Hong Kong and Singapore,citeseerx.ist.psu.edu/viewdoc/download? doi=10.1.1.200.432&rep=rep 1 &type=pdf。  new window
圖書論文
1.Thompson, Charis(2010)。Asian Regeneration? Nationalism and Internationalism in Stem Cell Research in South Korea and Singapore。Asian Biotech: Ethics and Communities of Fate。Durham, NC:Duke University Press。  new window
2.Tsui-Auch, Lai Si(2000)。Functional versus Sectoral Industrial Policy: A Comparative Study of the Biotechnology Development in Hong Kong and Singapore。Biotechnologie--GlobalisierungDemo- kratie: Politische Gestaltung transnationaler Technologieentwicklung。Berlin:Edition Sigma。  new window
3.Baark, Erik、Sharif, Naubahar(2006)。Hong Kong’s Innovation System in Transition。Asia’s Innovation Systems in Transition。Cheltenham, UK:Elgar。  new window
4.Chang, Albert Y.(1999)。The Role of Hong Kong SAR in the Development of Biotechnology Industry in China。Animal Cell Technology: Challenges for the Twenty-First Century。Dordrecht:Kluwer。  new window
5.Keller, William W.、Samuels, Richard J.(2003)。Innovation and the Asian Economies。Crisis and Innovation in Asian Technology。Cambridge:Cambridge University Press。  new window
6.Ong, Aihwa(2010)。An Analytics of Biotechnology and Ethics at Multiple Scales。Asian Biotech: Ethics and Communities of Fate。Durham, NC:Duke University Press。  new window
7.Wong, Joseph(2010)。Biotechnology in Hong Kong: Prospects and Challenges。Innovation Policy and the Limits of Laissez-Faire: Hong Kong’s Policy in Comparative Perspective。Basingstoke:Palgrave Macmillan。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關博士論文
 
無相關著作
 
1. 1930~1960年金雞納與奎寧在臺生命史--時空特徵與意義轉化
2. Book Review: Todd A. Henry, «Assimilating Seoul: Japanese Rule and the Politics of Public Space in Colonial Korea, 1910~1945» (Berkeley: University of California Press, 2014)
3. Between the West and Asia: "Humanistic" Japanese Family Planning in the Cold War
4. Biopolitical Knowledge in the Making: Population Politics and Fertility Studies in Early Cold War Taiwan
5. Population Control in Cold War Asia: An Introduction
6. Generating Local Needs through Technology: Global Comparisons in Diabetes Quality Management
7. Attention to Stem Cell Research in Japanese Mass Media: Twenty-Year Macrotrends and the Gap between Media Attention and Ethical, Legal, and Social Issues
8. 土地使用審議組織之委託代理關係分析--以內政部區域計畫委員會為例
9. From Racialization to World Citizenship: The Transnationality of Taiwan and the Early Psychiatric Epidemiological Studies of the World Health Organization
10. Mental Illness in Singapore: A History of a Colony, Port City, and Coolie Town
11. Making and Mapping Psy Sciences in East and Southeast Asia
12. Book Review: Vincanne Adams, Mona Schrempf, and Sienna R. Craig, eds., «Medicine between Science and Religion: Explorations on Tibetan Grounds»(New York: Berghahn Books, 2010)
13. Asians--a Doping-Friendly Race? Antidoping Research and Popular Discourse on Race in the Postgenomic Era
14. 改造尺度,治理愛滋:全球民族誌觀點
15. 臺灣汽車零組件產業的技術擴散與產業升級:從火藥、高壓氣瓶到安全氣囊
 
QR Code
QRCODE